ViaDerma Investor Information
ViaDerma, Inc. (OTC Pink: VDRM) is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development.
ViaDerma manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company’s lead products Vitastem & Vitastem Ultra are normally applied topically using a patent-pending topical delivery system technology.
Presently, the Vitastem first aid & topical antibiotic product is used within the OTC drug market, i.e. non-prescription. ViaDerma believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications.
In addition to the primary plan of developing and selling new products to the market, ViaDerma is exploring the possibility of licensing the technology to other industry leading pharmaceutical companies around the world.